Although incidence rates and mortality of gastric cancer are steadily decreasing with improved nutritional compositions and anti-HP antibody used, this disease still poses a huge threat to human health, leading to a poor diagnosis and prognosis for GC patients [3]. The gene discussed is HP; the disease is gastric cancer.